Kymberly K. Levine

Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment

P. A. Futreal, M. Stratton, A. Iafrate, 2007, Clinical Cancer Research.

A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Tracy T Batchelor, Richard Lugg, Andrew Menzies, 2006, Cancer research.

Human USP18 protects diverse cancer lineages from Type I Interferon independently of its canonical catalytic function

P. Loria, V. Frattini, B. Kessler, 2023, bioRxiv.

The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein-protein interactions.

Clayton Springer, Xiaoling Xie, Walter Michael, 2013, ACS medicinal chemistry letters.

Therapeutic Effects of FGF23 c‐tail Fc in a Murine Preclinical Model of X‐Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption

M. Mohammadi, Mark Horn, D. Aivazian, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers

Timothy L. Foley, K. Gajiwala, R. Kania, 2018, PloS one.